Tradestie Institutional Equity Comparison Engine

DYN vs IMCR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMCR Overall Edge

IMCR Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immunocore Holdings plc American Depositary Shares (IMCR) driven by superior Valuation, Options & Structure while DYN counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, DYN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMCR at 20.8x Forward P/E and -2.2% operating margin (-1.4% YoY). In options structure, DYN sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against IMCR sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IMCR
DYN N/M vs IMCR 20.8x Fwd P/E
Growth & Margin Winner DYN
Op Margin 0.0% vs -2.2% ยท YoY +0.0% vs -1.4%
Momentum & Technical Winner DYN
1Y -24.8% vs -31.7% ยท 52W Pos 11% vs 5%
Options & Structure Winner IMCR
BREAKDOWN (9th %ile IV) vs UNCLASSIFIED (10th %ile IV)
DYN NASDAQ
Dyne Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$15.50
-3.31% 1D
Market Cap $3.0B
1M Return -1.71%
1Y Return -24.76%
Forward P/E N/M
Unified AI Score
39.9 / 100 SELL
Tech 25.0 Fund 48.0 Flow 70.0 Mom 60.0
IMCR NASDAQ
Immunocore Holdings plc American Depositary Shares
Biological Products, (No Disgnostic Substances)
$26.41
-0.83% 1D
Market Cap $1.4B
1M Return -17.78%
1Y Return -31.67%
Forward P/E 20.8x
Unified AI Score
44.1 / 100 HOLD
Tech 33.0 Fund 47.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DYN -24.76% IMCR -31.67% Spread: +6.91 pp (DYN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DYN TTM Op. Margin: 0.0% IMCR TTM Op. Margin: -2.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DYN vs IMCR. Trailing 12-month operating profitability (DYN 0.0% vs IMCR -2.2%) and valuation multiples (DYN N/M vs IMCR 20.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DYN (5) vs IMCR (5)
Institutional Metric DYN IMCR Criterion Row Winner
Market Capitalization Scale $3.0B $1.4B Larger Scale DYN
Trailing P/E Ratio Valuation N/M 20.8x Lower Multiple IMCR
Forward P/E Ratio Valuation N/M 20.8x Lower Multiple IMCR
Revenue Growth (YoY) Growth +0.0% -1.4% Higher Growth DYN
Operating Margin (TTM) Profitability 0.0% -2.2% Higher Margin DYN
Net Profit Margin Profitability 0.0% -7.5% Higher Margin DYN
Return on Equity (ROE) Capital Efficiency -74.6% -7.9% Higher ROE IMCR
52-Week Range Position Momentum 11% ($14โ€“$27) 5% ($26โ€“$41) Stronger Trend DYN
Beta / 30D Volatility Risk Regime 1.55ฮฒ ยท 55% Vol 0.63ฮฒ ยท 49% Vol Lower Realized Risk IMCR
Unified Institutional Score Composite Signal 39.9 / 100 (SELL) 44.1 / 100 (HOLD) Higher Composite IMCR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DYN vs IMCR Buy Guide
DYN BREAKDOWN
72d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live DYN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMCR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live IMCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DYN nor IMCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.